Global Inequities in Diabetes Technology and Insulin Access and Glycemic Outcomes
JAMA Network Open 10.1001/jamanetworkopen.2025.28933August 27, 2025 at 11:00 AM EDT
How is global disparity in access to diabetes technologies and insulin associated with glycemic outcomes in children with type 1 diabetes (T1D)?This cross-sectional study collated data regarding the accessibility and reimbursement of diabetes technologies and insulin from 81 centers across 56 countries, inclusive of 42 349 children with T1D. Significant global disparity and an association between glycemic outcomes and the accessibility of diabetes technologies and insulin were found.Global efforts must be made to ensure universal accessibility to insulin and diabetes technologies and thereby improve disparity in glycemic outcomes for children with T1D.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.